Kardium has a total of 257 patents globally, out of which 168 have been granted. Of these 257 patents, more than 80% patents are active. The United States of America is where Kardium has filed the maximum number of patents, followed by Europe (EPO) and Germany. Parallelly, The United States of America seems to be the main focused R&D center and also the USA is the origin country of Kardium.
Kardium was founded in the year 2007. The Company develops medical devices for the diagnosis and treatment of atrial fibrillation.
Do read about some of the most popular patents of Kardium which have been covered by us in this article and also you can find Kardium patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Kardium patent portfolio.
How many patents does Kardium have?
Kardium has a total of 257 patents globally. These patents belong to 58 unique patent families. Out of 257 patents, 208 patents are active.
How Many Patents did Kardium File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
|Year of Patents Filing or Grant||Kardium Applications Filed||Kardium Patents Granted|
How many Kardium patents are Alive/Dead?
How Many Patents did Kardium File in Different Countries?
Countries in which Kardium Filed Patents
|United States Of America||165|
Where are the Research Centers of Kardium Patents Located?
10 Best Kardium Patents
US20110082538A1 is the most popular patent in the Kardium portfolio. It has received 1346 citations so far from companies like Valtech Cardio Ltd, Ethicon Llc and Edwards Lifesciences Corporation.
Below is the list of 10 most cited patents of Kardium:
|Publication Number||Citation Count|
How many inventions of other companies were rejected due to Kardium patents?
The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Kardium invention. They couldn’t because Kardium had protected those before them.
Examiners at the USPTO referred 30 Kardium patents in 170 rejections (35 USC § 102 or 35 USC § 103 types).
The top citing companies in the Kardium patent portfolio are Biosense Webster Israel Ltd, Edwards Lifesciences, and Warsaw Orthopedic Inc.
List of the Companies whose Patents were rejected citing Kardium –
|Company||Number of Patent Applications that faced Rejection Citing Kardium Patents||Number of Rejections (102 & 103)|
|Biosense Webster Israel Ltd||9||20|
|Warsaw Orthopedic Inc||3||7|
|Boston Scientific Scimed Inc||3||4|
|Cardiac Implants Llc||2||8|
|Manual Surgical Sciences Llc||2||3|
|Valtech Cardio Ltd||2||2|
|Epix Therapeutics Inc||2||2|
Count of 102 and 103 Type Rejections based on Kardium Patents
Top Kardium Patents used in Rejecting Most Patent Applications
|Patent Number||Count of Rejected Applications|
What Percentage of Kardium US Patent Applications were Granted?
Kardium (Excluding its subsidiaries) has filed 156 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 115 have been granted leading to a grant rate of 94.2%.
Below are the key stats of Kardium patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Kardium?
|Law Firm||Total Applications||Success Rate|
|Rossi Kimms & Mcdowell Llp||143||99.08%|
|Seed Intellectual Property Law Group Llp||13||53.85%|
What are Kardium‘s key innovation segments?
What Technologies are Covered by Kardium?
The chart below distributes patents filed by Kardium